MGOSX
Price
$15.48
Change
-$0.07 (-0.45%)
Updated
Sep 20 closing price
RPTIX
Price
$109.40
Change
-$0.77 (-0.70%)
Updated
Sep 20 closing price
Ad is loading...

MGOSX vs RPTIX

Header iconMGOSX vs RPTIX Comparison
Open Charts MGOSX vs RPTIXBanner chart's image
Victory Munder Mid-Cap Core Growth R6
Price$15.48
Change-$0.07 (-0.45%)
VolumeN/A
CapitalizationN/A
T. Rowe Price Mid-Cap Growth I
Price$109.40
Change-$0.77 (-0.70%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
MGOSX vs RPTIX Comparison Chart
Loading...
VS
MGOSX vs. RPTIX commentary
Sep 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MGOSX is a Buy and RPTIX is a StrongBuy.

FUNDAMENTALS
Fundamentals
RPTIX has more cash in the bank: 31.4B vs. MGOSX (318M). RPTIX pays higher dividends than MGOSX: RPTIX (0.18) vs MGOSX (0.00). MGOSX was incepted earlier than RPTIX: MGOSX (12 years) vs RPTIX (9 years). MGOSX is a more actively managed with annual turnover of: 60.00 vs. RPTIX (21.70). MGOSX has a lower initial minimum investment than RPTIX: MGOSX (0) vs RPTIX (500000). MGOSX annual gain was more profitable for investors over the last year : 20.92 vs. RPTIX (14.81). RPTIX return over 5 years is better than : 15.09 vs. MGOSX (-40.65).
MGOSXRPTIXMGOSX / RPTIX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence12 years9 years-
Gain YTD12.8459.127141%
Front LoadN/AN/A-
Min. Initial Investment0500000-
Min. Initial Investment IRAN/AN/A-
Net Assets318M31.4B1%
Annual Yield % from dividends0.000.18-
Returns for 1 year20.9214.81141%
Returns for 3 years-23.50-13.57173%
Returns for 5 years-40.6515.09-269%
Returns for 10 years-65.59N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CLH246.88-0.54
-0.22%
Clean Harbors
TOI0.29N/A
-0.58%
Oncology Institute (The)
CINT6.59-0.04
-0.60%
CI&T
CSTM16.22-0.54
-3.22%
Constellium SE
KTTA4.43-0.37
-7.71%
Pasithea Therapeutics Corp